3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Oxaliplatin
2
Fluorouracil
2
tremelimumab
1
pembrolizumab
1
monalizumab
1
epacadostat
1
durvalumab
1
Surgical Procedures, Operative
1
Nivolumab
1
Metabolic Networks and Pathways
1
Leucovorin
1
Immune Checkpoint Inhibitors
1
Fecal Microbiota Transplantation
1
Biopsy
1
AMG 337
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Adenocarcinoma Of Esophagus
×
monalizumab
×
Clear all
NCT03307941
2017-12-19
ARTEMIS-Eso
Jules Bordet Institute
Phase 1/2
Withdrawn